vimarsana.com

Page 3 - ஆர்யா அறிவியல் கையகப்படுத்தல் கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins

Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

SPACs are Back!

2 SPACs Vote Tomorrow amid June Merger Frenzy

Chamath Files 4 New Biotech SPACs

Chamath Files 4 New Biotech SPACs Today s SPAC highlight came post market as Chamath dropped four new SPAC S-1s for $800M total. JWS vote passes, with TSIA and JIH set to vote tomorrow. Author: In another win on Day-1 of new De-SPAC ticker trading, BARK, which just closed its merger with Northern Star Acquisition Co. (STIC) rose nearly 7%. One more example of a recent De-SPAC that has traded up shortly after, following SOFI early this week and others last month. Investors will be sure to watch this price action for future De-SPACs, and, with over 20 this month there are plenty to keep an eye out for (list below). 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.